Skip to main content

Table 7 In silico drug-likeness and ADMET parameters of the top two docked phytochemicals

From: Probing the multitargeting potential of n-hexane fraction of Gongronema latifolium leaves in neurodegeneration via in vitro, GC–MS and in silico studies

 

Dihydroactinidiolide

1H-Indole-3-ethanamine

Thymol

Molecular weight (g/mol)

180.24

160.22

150.22

Num. arom. Heavy atoms

0

9

6

Num. heavy atoms

13

12

11

Num. H-bond acceptors

2

1

1

Num. rotatable bonds

0

2

1

Hydrogen bond donor

0

2

1

cLogP

2.29

1.54

2.32

Molar refractivity

51.35

50.78

48.01

TPSA (Å2)

26.30

41.81

20.23

Drug-likeness

Lipinski

Yes

Yes

Yes

Veber

Yes

Yes

Yes

Ghose

Yes

Yes

No (MW < 160)

Egan

Yes

Yes

Yes

Bioavailability score

0.55

0.55

0.17

Absorption (probability)

(b) Admet SAR

HIA

HIA + (1.0)

HIA + (0.767)

HIA + (0.805)

Blood–brain barrier

BBB + (0.9545)

BBB + (0.939)

BBB + (0.0568)

P-glycoprotein substrate

Negative (0.5333)

Negative (0.279)

Negative (0. 037)

Caco-2 permeability Cm/s

Caco2 + (0.6787)

Caco2 + (0.066)

Caco2 + (0.576)

Distribution (probability)

PPB %

64.639

53.854

80.06

Metabolism (probability)

CYP450 1A2 inhibitor

Negative (0.563)

Positive (0.968)

Positive (0.799)

CYP450 1A2 substrate

Negative (0.408)

Positive (0.556)

Positive (0.566)

CYP450 3A4 inhibitor

Negative (0.866)

Negative (0.205)

Negative (0.118)

CYP450 2C9 inhibitor

Negative (0.900)

Negative (0.049)

Negative (0.337)

CYP450 2C9 substrate

Negative (0.8401)

Negative (0.607)

Negative (0.643)

CYP450 2C19 inhibitor

Positive (0.5211)

Negative (0.122)

Negative (0.735)

CYP450 2C19 substrate

Negative (0.452)

Positive (0.452)

Positive (0.491)

CYP450 2D6 inhibitor

Negative (0.922)

Negative (0.9022)

Negative (0.386)

CYP450 2D6 substrate

Negative (0.922)

Negative (0.505)

Positive (0.72)

Elimination

T1/2 (half life time)

0.013 h

1.216 h

1.313 h

CL (clearance rate) mL/min/kg

13.57

2.29

2.235

Toxicity

hERG blockers

Negative (0.235)

Negative (0.222)

Negative (0.899)

AMES

Negative (0.937)

Negative (0.933)

Negative (0.928)

Carcinogen

Negative (0.918)

Negative (0.925)

Negative (0.719)

SkinSen

Negative (0.713)

Negative (0.236)

Negative (0.235)

LD50 (LD50 of acute toxicity)

1.948 -log mol/kg (2031.74 mg/kg)

2.497 -log mol/kg (510.172 mg/kg)

2.705 -log mol/kg (507.65 mg/kg)

  1. ADMET absorption, distribution, metabolism, elimination, and toxicity, BBB blood–brain barrier, GI: CYP cytochrome P450, P-gp permeability glycoprotein, hERG human Ether-à-go-go-Related Gene, Gastro-intestinal, H-HT human hepatotoxicity AMES, HIA human intestinal absorption, DILI drug-induced liver injury, VD volume distribution, Ames mutagenicity, PPB plasma protein binding